| 1 |
[Minireview]The rationale and potential for using Lactobacillus in the management of periodontitis
|
Jiaqi Wang1, Yingman Liu1, Weiru Wang1, Jiaojiao Ma1, Manman Zhang2, Xiaoying Lu2, Jie Liu3, and Yurong Kou1,2* |
vol.60,No.4,2022 |
355-363 |
| 2 |
Cytophaga hutchinsonii chu_2177, encoding the O-antigen ligase, is essential for cellulose degradation
|
Yahong Tan1, Wenxia Song1, Lijuan Gao1,2, Weican Zhang1, and Xuemei Lu1* |
vol.60,No.4,2022 |
364-374 |
| 3 |
Characterization of a cold-adapted debranching enzyme and its role in glycogen metabolism and virulence of Vibrio vulnificus MO6-24/O
|
Ah-Reum Han1, Haeyoung Kim1, Jong-Tae Park2, and Jung-Wan Kim1,3* |
vol.60,No.4,2022 |
375-386 |
| 4 |
Characterization of components of a reducing system for SoxR in the cytoplasmic membrane of Escherichia coli
|
Kang-Lok Lee1*, Kyung-Chang Lee2, Joon-Hee Lee3, and Jung-Hye Roe2 |
vol.60,No.4,2022 |
387-394 |
| 5 |
Structural and biochemical analysis of the PTPN4 PDZ domain bound to the C-terminal tail of the human papillomavirus E6 oncoprotein
|
Hye Seon Lee1, Hye-Yeoung Yun1,2, Eun-Woo Lee3, Ho-Chul Shin1, Seung Jun Kim1,2*, and Bonsu Ku1,2* |
vol.60,No.4,2022 |
395-401 |
| 6 |
Down-regulation of microRNA-155 suppressed Candida albicans induced acute lung injury by activating SOCS1 and inhibiting inflammation response
|
Xiaohua Li1,2, Yuanzhong Gong3, Xin Lin1, Qiong Lin1, Jianxiong Luo1, Tianxing Yu1, Junping Xu1, Lifang Chen1, Liyu Xu1*, and Ying Hu1* |
vol.60,No.4,2022 |
402-410 |
| 7 |
Regulatory role of cysteines in (2R, 3R)-butanediol dehydrogenase BdhA of Bacillus velezensis strain GH1-13
|
Yunhee Choi1 and Yong-Hak Kim2* |
vol.60,No.4,2022 |
411-418 |
| 8 |
Gut microbiota metabolic characteristics in coronary artery disease patients with hyperhomocysteine
|
Ran Tian1, Hong-Hong Liu1, Si-Qin Feng1, Yi-Fei Wang2,3, Yi-Yang Wang2, Yu-Xiong Chen1, Hui Wang1, and Shu-Yang Zhang1* |
vol.60,No.4,2022 |
419-428 |
| 9 |
Alterations of oral microbiota in Chinese children with viral encephalitis and/or viral meningitis
|
Yijie Li1,2, Jing Liu3, Yimin Zhu1,2, Chunying Peng3, Yao Dong1,2, Lili Liu1,2, Yining He1,2, Guoping Lu3*, and Yingjie Zheng1,2,4* |
vol.60,No.4,2022 |
429-437 |
| 10 |
The novel antifungal agent AB-22 displays in vitro activity against hyphal growth and biofilm formation in Candida albicans and potency for treating systemic candidiasis
|
Kyung-Tae Lee1, Dong-Gi Lee2, Ji Won Choi3,4, Jong-Hyun Park3,4, Ki Duk Park3,4, Jong-Seung Lee2*, and Yong-Sun Bahn1* |
vol.60,No.4,2022 |
438-443 |
| 11 |
Lipocalin2 as a potential antibacterial drug against Acinetobacter baumannii infection
|
Daejin Lim1, Su-Jin Park2, Ha Young Kim3, Minsang Shin4, and Miryoung Song5* |
vol.60,No.4,2022 |
444-449 |
